Davide Serrano

21PUBLICATIONS
98CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 31, 2026
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

|Oct 30, 2025
Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.

Irene Maria Briata, Stefano Spinaci, Parijatham S Thomas

|Oct 16, 2025
Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study.

Silvia Polidoro, Harriet Johansson, Giovanni Cugliari

|Jun 09, 2025
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention.

G Aurilio, D Serrano, M Lazzeroni

|Apr 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial.

Harriet Johansson, Debora Macis, Martino Oliva

|Jan 25, 2025
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies.

Eliza Del Fiol Manna, Davide Serrano, Laura Cazzaniga

Pageof 4

Frequent Collaborators

16 joint publications

Lucio Bertario

12 joint publications

Aliana Guerrieri-Gonzaga

11 joint publications

Matteo Lazzeroni

8 joint publications

Harriet Johansson